Valuation: LeMaitre Vascular, Inc.

Market Cap 1.84B 1.59B 1.51B 1.37B 2.56B 176B 2.58B 17.97B 6.95B 89.44B 6.91B 6.75B 285B P/E 2026 *
28x
P/E 2027 * 25.3x
Enterprise Value 1.6B 1.38B 1.31B 1.19B 2.23B 153B 2.24B 15.62B 6.04B 77.74B 6B 5.87B 248B EV / Sales 2026 *
5.78x
EV / Sales 2027 * 5.08x
Free-Float
87.26%
Yield 2026 *
1.24%
Yield 2027 * 1.39%
1 day+1.47%
1 week+4.55%
Current month+0.73%
1 month-2.13%
3 months-12.66%
6 months-28.12%
Current year-1.43%
1 week 67.5
Extreme 67.5
69
1 month 66
Extreme 66
71
Current year 66
Extreme 66
99
1 year 66
Extreme 66
99
3 years 42
Extreme 42
102
5 years 35.4
Extreme 35.4
102
10 years 19.1
Extreme 19.1
102
Manager TitleAgeSince
Chief Executive Officer 61 01/06/1992
Director of Finance/CFO 51 10/03/2025
Director of Finance/CFO 62 01/01/2000
Director TitleAgeSince
Director/Board Member 68 01/01/2003
Chairman 61 01/01/2004
Director/Board Member 61 24/10/2016
Change 5-day change 1-year change 3-year change Capi.($)
+1.47%+4.55% - - 1.84B
+1.10%+7.06%+34.88%+25.78% 237B
-0.48%+1.71%+9.39%-18.37% 147B
+1.36%+8.22%-12.02%+29.35% 133B
+0.09%-2.34%-55.64%-16.99% 63.58B
-1.31%-0.85%-19.46%-16.84% 49.95B
+4.13%+3.60%+18.90%+21.97% 49.42B
+2.28%+6.18%+20.83%+32.59% 42.37B
+0.37%+3.42%+38.13%+51.79% 40.98B
-0.52%+3.77%-16.27%+56.99% 32.82B
Average +0.85%+2.94%+2.08%+18.47% 88.52B
Weighted average by Cap. +0.77%+4.15%+8.02%+14.89%

Financials

2026 *2027 *
Net sales 277M 240M 227M 206M 385M 26.53B 388M 2.7B 1.04B 13.46B 1.04B 1.02B 42.89B 303M 263M 248M 225M 422M 29.06B 425M 2.96B 1.14B 14.74B 1.14B 1.11B 46.98B
Net income 66.71M 57.81M 54.64M 49.61M 92.98M 6.4B 93.53M 652M 252M 3.25B 251M 245M 10.35B 74.29M 64.38M 60.85M 55.24M 104M 7.13B 104M 726M 281M 3.61B 279M 273M 11.52B
Net Debt -240M -208M -197M -179M -335M -23.07B -337M -2.35B -909M -11.7B -903M -883M -37.3B -300M -260M -246M -223M -419M -28.82B -421M -2.94B -1.14B -14.62B -1.13B -1.1B -46.59B
Logo LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which are used in open vascular surgery and dialysis access. It offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold globally in the United States, Europe, Canada and Asia Pacific.
Employees
651
Date Price Change
16/09/26 €69.00 +1.47%
15/09/26 €68.00 0.00%
14/09/26 €68.00 +0.74%
11/09/26 €67.50 -0.74%
10/09/26 €68.00 +3.03%
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
80.38USD
Average target price
107.00USD
Spread / Average Target
+33.12%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!